Iomai (United States)

Recent papers from Iomai (United States)

1. Sequential Event Rate MonitoringStatistics in Medicine · 2026
2. Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesinVaccine · 2019
3. Protection against Shiga Toxin-ProducingEscherichia coliInfection by Transcutaneous Immunization with Shiga Toxin Subunit BClinical and Vaccine Immunology · 2007
4. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchExpert Review of Vaccines · 2007
5. Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum CorneumInfection and Immunity · 2007
6. GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal ImmunoadjuvantThe Journal of Immunology · 2006
7. Fabry disease and vascular risk factors: future strategies for patient‐based studies and the knockout murine modelActa Paediatrica · 2006
8. Dose Sparing with Intradermal Injection of Influenza VaccineNew England Journal of Medicine · 2004
9. Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged MiceJournal of Virology · 2004
10. Immunostimulant Patch Containing Heat-Labile Enterotoxin fromEscherichia coliEnhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic CellsJournal of Virology · 2003
11. Survey of human-use adjuvantsExpert Review of Vaccines · 2003
12. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skinExpert Review of Vaccines · 2003
13. The increasing scope of training and development competencyBenchmarking An International Journal · 2002
14. Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated AdjuvantsInfection and Immunity · 2000